Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $57.75 USD
Change Today +0.15 / 0.26%
Volume 8.5M
MRK On Other Exchanges
Symbol
Exchange
New York
Mexico
EN Paris
Sao Paulo
Frankfurt
As of 8:04 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for merck & co. inc. (MRK)

Although debt as a percent of total capital decreased at Merck & Co. Inc. over the last fiscal year to 30.51%, it is still in-line with the Pharmaceuticals industry's norm. Additionally, there are enough liquid assets to satisfy current obligations. Accounts Receivable are typical for the industry, with 61.06 days worth of sales outstanding. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 141.77 days.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Reclassified
Dec 31
2012
Reclassified
Dec 31
2013
Reclassified
Dec 31
2014
4 Year
Trend
Assets    
Cash and Equivalents13,531.013,451.015,621.07,441.0
Short-Term Investments1,441.02,690.01,865.08,278.0
TOTAL CASH AND SHORT TERM INVESTMENTS14,972.016,141.017,486.015,719.0
Accounts Receivable8,261.07,672.07,461.06,671.0
Other Receivables276.0302.0----
TOTAL RECEIVABLES8,537.07,974.07,461.06,671.0
Inventory6,254.06,535.06,226.05,571.0
Deferred Tax Assets, Current827.0624.0572.0568.0
Other Current Assets2,591.03,583.03,940.04,644.0
TOTAL CURRENT ASSETS33,181.034,857.035,685.033,173.0
Gross Property Plant and Equipment32,473.033,415.033,094.031,140.0
Accumulated Depreciation-16,176.0-17,385.0-18,121.0-18,004.0
NET PROPERTY PLANT AND EQUIPMENT16,297.016,030.014,973.013,136.0
Goodwill12,155.012,134.012,301.012,992.0
Long-Term Investments4,344.08,605.011,383.013,871.0
Accounts Receivable, Long Term--473.0275.080.0
Deferred Tax Assets, Long Term497.0527.0381.0401.0
Other Intangibles34,302.029,083.023,801.020,386.0
Other Long-Term Assets4,352.04,423.06,846.04,296.0
TOTAL ASSETS105,128.0106,132.0105,645.098,335.0
    
LIABILITIES & EQUITY    
Accounts Payable2,023.01,753.02,274.02,625.0
Accrued Expenses9,736.09,203.08,690.09,035.0
Short-Term Borrowings1,990.02,515.02,421.01,704.0
Current Portion of Long-Term Debt/Capital Lease--1,800.02,100.01,000.0
Current Income Taxes Payable781.01,200.0251.01,606.0
Other Current Liabilities, Total1,715.01,877.02,132.02,796.0
TOTAL CURRENT LIABILITIES16,245.018,348.017,868.018,766.0
Long-Term Debt15,525.016,254.020,564.018,714.0
Minority Interest2,426.02,443.02,561.0144.0
Pension & Other Post-Retirement Benefits3,805.03,989.01,786.02,480.0
Deferred Tax Liability Non-Current5,626.05,740.06,776.04,266.0
Other Non-Current Liabilities6,984.06,338.06,325.05,318.0
TOTAL LIABILITIES48,185.050,669.053,319.049,544.0
Common Stock1,788.01,788.01,788.01,788.0
Additional Paid in Capital40,663.040,646.040,508.040,423.0
Retained Earnings38,990.039,985.039,257.046,021.0
Treasury Stock-23,792.0-24,717.0-29,591.0-35,262.0
Comprehensive Income and Other-3,132.0-4,682.0-2,197.0-4,323.0
TOTAL COMMON EQUITY54,517.053,020.049,765.048,647.0
TOTAL EQUITY56,943.055,463.052,326.048,791.0
TOTAL LIABILITIES AND EQUITY105,128.0106,132.0105,645.098,335.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:US $57.75 USD +0.15

MRK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
3M Co $163.50 USD +0.91
Bayer AG €139.61 EUR +0.422
Gilead Sciences Inc $101.00 USD -0.075
Pfizer Inc $34.53 USD +0.37
Sanofi €91.69 EUR +0.31
View Industry Companies
 

Industry Analysis

MRK

Industry Average

Valuation MRK Industry Range
Price/Earnings 14.2x
Price/Sales 3.9x
Price/Book 3.4x
Price/Cash Flow 13.8x
TEV/Sales 3.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.